Colorectal Cancer Surgery Quality in Manitoba: A Population-Based Descriptive Analysis.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
16 06 2021
Historique:
received: 18 05 2021
revised: 02 06 2021
accepted: 08 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 25 9 2021
Statut: epublish

Résumé

Unwarranted clinical variation in healthcare impacts access, productivity, performance, and outcomes. A strategy proposed for reducing unwarranted clinical variation is to ensure that population-based data describing the current state of health care services are available to clinicians and healthcare decision-makers. The objective of this study was to measure variation in colorectal cancer surgical treatment patterns and surgical quality in Manitoba and identify areas for improvement. This descriptive study included individuals aged 20 years or older who were diagnosed with invasive cancer (adenocarcinoma) of the colon or rectum between 1 January 2010 and 31 December 2014. Laparoscopic surgery was higher in colon cancer (24.1%) compared to rectal cancer (13.6%). For colon cancer, the percentage of laparoscopic surgery ranged from 12.9% to 29.2%, with significant differences by regional health authority (RHA) of surgery. In 86.1% of colon cancers, ≥12 lymph nodes were removed. In Manitoba, the negative circumferential resection margin for rectal cancers was 96.9%, and ranged from 96.0% to 100.0% between RHAs. The median time between first colonoscopy and resection was 40 days for individuals with colon cancer. This study showed that high-quality colorectal cancer surgery is being conducted in Manitoba along with some variation and gaps in quality. As a result of this work, a formal structure for ongoing measuring and reporting surgical quality has been established in Manitoba. Quality improvement initiatives have been implemented based on these findings and periodic assessments of colorectal cancer surgery quality will continue.

Identifiants

pubmed: 34208635
pii: curroncol28030206
doi: 10.3390/curroncol28030206
pmc: PMC8293066
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2239-2247

Références

BMC Surg. 2013;13 Suppl 2:S12
pubmed: 24267544
Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S33-5
pubmed: 19461921
CMAJ Open. 2018 Sep 18;6(3):E384-E390
pubmed: 30228155
J Laparoendosc Adv Surg Tech A. 2013 Jan;23(1):1-7
pubmed: 23004676
J Am Med Inform Assoc. 2018 Mar 1;25(3):224-229
pubmed: 29025002
J Am Coll Surg. 2007 Nov;205(5):636-41
pubmed: 17964438
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):438-41
pubmed: 18613383
J Surg Oncol. 2013 Nov;108(6):378-84
pubmed: 24037666
Health Place. 1999 Jun;5(2):157-71
pubmed: 10670997
Dis Colon Rectum. 2017 Oct;60(10):999-1017
pubmed: 28891842
Can J Public Health. 2012 Jul 04;103(8 Suppl 2):S23-7
pubmed: 23618067
BMC Res Notes. 2013 Sep 06;6:355
pubmed: 24010527
J Clin Oncol. 2008 Jan 10;26(2):303-12
pubmed: 18182672
Dis Colon Rectum. 2020 Feb;63(2):160-171
pubmed: 31842159
BMC Cancer. 2014 Aug 31;14:642
pubmed: 25175937
Curr Oncol. 2021 Jan 19;28(1):581-592
pubmed: 33478040
Lancet. 2013 Sep 28;382(9898):1121-9
pubmed: 24075052
Science. 1973 Dec 14;182(4117):1102-8
pubmed: 4750608
Dis Colon Rectum. 2018 Apr;61(4):433-440
pubmed: 29521824
Curr Oncol. 2015 Feb;22(1):60-3
pubmed: 25684989
Cancer Res Treat. 2018 Apr;50(2):506-517
pubmed: 28546522
Perm J. 2009 Winter;13(1):47-52
pubmed: 21373245
CMAJ. 2017 Mar 6;189(9):E375-E376
pubmed: 28280071
Can Fam Physician. 2016 Oct;62(10):e599-e607
pubmed: 27737995

Auteurs

Iresha Ratnayake (I)

Department of Epidemiology & Cancer Registry, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.

Jason Park (J)

Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Natalie Biswanger (N)

Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Screening Programs, CancerCare Manitoba, Winnipeg, MB R3C 2B1, Canada.

Allison Feely (A)

Department of Epidemiology & Cancer Registry, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Grace Musto (G)

Department of Epidemiology & Cancer Registry, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Kathleen Decker (K)

Department of Epidemiology & Cancer Registry, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Research Institute in Oncology & Hematology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH